KEGG   PATHWAY: cpoc05169
Entry
cpoc05169                   Pathway                                
Name
Epstein-Barr virus infection - Cavia porcellus (domestic guinea pig)
Description
Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin's lymphoma, Burkitt's lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases.  EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.
Class
Human Diseases; Infectious disease: viral
Pathway map
cpoc05169  Epstein-Barr virus infection
cpoc05169

Organism
Cavia porcellus (domestic guinea pig) [GN:cpoc]
Gene
101787675  Cr2; LOW QUALITY PROTEIN: complement receptor type 2 [KO:K04012]
100135497  Cd19; B-lymphocyte antigen CD19 isoform X1 [KO:K06465]
100718695  rano class II histocompatibility antigen, A beta chain-like [KO:K06752]
100720632  HLA class II histocompatibility antigen, DRB1-10 beta chain-like [KO:K06752]
100717851  HLA class II histocompatibility antigen, DO beta chain [KO:K06752]
100718133  HLA class II histocompatibility antigen, DQ beta 1 chain-like [KO:K06752]
100713671  HLA class II histocompatibility antigen, DP alpha 1 chain-like [KO:K06752]
100714501  HLA class II histocompatibility antigen, DP beta 1 chain [KO:K06752]
100714780  HLA class II histocompatibility antigen, DP beta 1 chain-like [KO:K06752]
100715615  HLA class II histocompatibility antigen, DP alpha 1 chain-like isoform X1 [KO:K06752]
100716183  HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
100716469  HLA class II histocompatibility antigen, DM beta chain [KO:K06752]
100719246  HLA class II histocompatibility antigen, DRB1-16 beta chain [KO:K06752]
100735392  HLA class II histocompatibility antigen, DQ alpha 1 chain-like [KO:K06752]
100735670  SLA class II histocompatibility antigen, DQ haplotype D alpha chain-like [KO:K06752]
100735949  HLA class II histocompatibility antigen, DR alpha chain [KO:K06752]
100720894  HLA class II histocompatibility antigen, DRB1-1 beta chain-like [KO:K06752]
100715902  uncharacterized protein LOC100715902 [KO:K06752]
100719800  HLA class II histocompatibility antigen, DRB1-1 beta chain-like [KO:K06752]
100717682  Tlr2; toll-like receptor 2 [KO:K10159]
100733381  Myd88; myeloid differentiation primary response protein MyD88 [KO:K04729]
100729751  Irak4; LOW QUALITY PROTEIN: interleukin-1 receptor-associated kinase 4 [KO:K04733] [EC:2.7.11.1]
100735146  Irak1; interleukin-1 receptor-associated kinase 1 isoform X1 [KO:K04730] [EC:2.7.11.1]
100724447  Traf6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
100735373  Tab1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
100717911  Tab2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
100718100  Map3k7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
100726357  Chuk; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
100724538  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
100722308  Ikbkg; NF-kappa-B essential modulator isoform X1 [KO:K07210]
100723189  Nfkbia; NF-kappa-B inhibitor alpha [KO:K04734]
100730075  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
100724366  Rela; transcription factor p65 isoform X1 [KO:K04735]
100135630  Tnf; tumor necrosis factor [KO:K03156]
106027696  Il6; interleukin-6 [KO:K05405]
100718491  Ddx58; probable ATP-dependent RNA helicase DDX58 [KO:K12646] [EC:5.6.2.6]
100712673  Mavs; mitochondrial antiviral-signaling protein [KO:K12648]
100734492  Traf3; TNF receptor-associated factor 3 isoform X2 [KO:K03174]
100731956  Tbk1; serine/threonine-protein kinase TBK1 isoform X2 [KO:K05410] [EC:2.7.11.10]
100716187  Ikbke; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1 [KO:K07211] [EC:2.7.11.10]
101788200  Irf7; interferon regulatory factor 7 isoform X1 [KO:K09447]
100724910  Irf3; LOW QUALITY PROTEIN: interferon regulatory factor 3 [KO:K05411]
100726990  interferon alpha-17-like [KO:K05414]
100728098  interferon alpha-4 [KO:K05414]
100729220  interferon alpha-21-like [KO:K05414]
100735600  interferon alpha-21-like [KO:K05414]
100722772  interferon alpha-1-like [KO:K05414]
100734117  interferon alpha-4-like [KO:K05414]
100718817  interferon alpha-17-like [KO:K05414]
100716684  interferon alpha-4-like [KO:K05414]
100728479  interferon alpha-17-like [KO:K05414]
100722040  interferon alpha-5-like [KO:K05414]
100717234  interferon alpha-17-like [KO:K05414]
100720391  interferon alpha-4-like [KO:K05414]
100725261  interferon alpha-4 [KO:K05414]
100730474  interferon alpha-4-like [KO:K05414]
100734169  interferon alpha-10-like [KO:K05414]
100721849  interferon alpha-17-like [KO:K05414]
100717707  LOW QUALITY PROTEIN: interferon alpha-2-like [KO:K05414]
100724988  interferon alpha-17-like [KO:K05414]
100714884  interferon alpha-13-like [KO:K05414]
100734449  interferon beta [KO:K05415]
100733284  interferon beta-like [KO:K05415]
111757491  Ifnb1; interferon beta [KO:K05415]
100715784  Ifnar1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
100716349  Ifnar2; interferon alpha/beta receptor 2 isoform X2 [KO:K05131]
100726895  Jak1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
100715734  Tyk2; non-receptor tyrosine-protein kinase TYK2 isoform X1 [KO:K11219] [EC:2.7.10.2]
100724708  Stat1; LOW QUALITY PROTEIN: signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
100719719  Stat2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221]
100714136  Irf9; interferon regulatory factor 9 isoform X1 [KO:K04693]
100717384  Eif2ak2; interferon-induced, double-stranded RNA-activated protein kinase [KO:K16195] [EC:2.7.11.1]
100721851  Oas1; 2'-5'-oligoadenylate synthase 1 [KO:K14216] [EC:2.7.7.84]
100722126  LOW QUALITY PROTEIN: 2'-5'-oligoadenylate synthase 3 [KO:K14216] [EC:2.7.7.84]
100714889  Cxcl10; C-X-C motif chemokine 10 [KO:K12671]
100731608  Isg15; ubiquitin-like protein ISG15 [KO:K12159]
100726403  Fas; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
100730628  Fadd; FAS-associated death domain protein [KO:K02373]
100713334  Casp8; caspase-8 [KO:K04398] [EC:3.4.22.61]
100728186  Bid; BH3-interacting domain death agonist [KO:K04726]
100725284  Bcl2l11; bcl-2-like protein 11 isoform X1 [KO:K16341]
100733337  Bcl2; LOW QUALITY PROTEIN: apoptosis regulator Bcl-2 [KO:K02161]
100730890  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
100734553  Bak1; bcl-2 homologous antagonist/killer isoform X2 [KO:K14021]
100731649  LOW QUALITY PROTEIN: cytochrome c, somatic [KO:K08738]
100733235  LOW QUALITY PROTEIN: cytochrome c, somatic-like [KO:K08738]
100724240  cytochrome c-like [KO:K08738]
100719903  Apaf1; apoptotic protease-activating factor 1 [KO:K02084]
100714954  Casp9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
100718309  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
100727781  Cd3e; T-cell surface glycoprotein CD3 epsilon chain isoform X2 [KO:K06451]
100726670  Cd3g; T-cell surface glycoprotein CD3 gamma chain [KO:K06452]
100727506  Cd3d; T-cell surface glycoprotein CD3 delta chain [KO:K06450]
100736201  Cd247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
100723641  Psmc2; 26S proteasome regulatory subunit 7 [KO:K03061]
100733985  Psmc1; 26S proteasome regulatory subunit 4 [KO:K03062]
100727625  Psmc4; 26S proteasome regulatory subunit 6B [KO:K03063]
100732212  Psmc6; 26S proteasome regulatory subunit 10B [KO:K03064]
101788057  26S proteasome regulatory subunit 10B [KO:K03064]
100727371  Psmc3; 26S proteasome regulatory subunit 6A [KO:K03065]
100717173  Psmc5; 26S proteasome regulatory subunit 8 isoform X1 [KO:K03066]
100725505  Psmd2; 26S proteasome non-ATPase regulatory subunit 2 [KO:K03028]
100736234  Psmd1; 26S proteasome non-ATPase regulatory subunit 1 [KO:K03032]
100725725  Psmd3; 26S proteasome non-ATPase regulatory subunit 3 [KO:K03033]
100719676  Psmd12; 26S proteasome non-ATPase regulatory subunit 12 [KO:K03035]
100718311  Psmd11; 26S proteasome non-ATPase regulatory subunit 11 [KO:K03036]
100715202  Psmd6; 26S proteasome non-ATPase regulatory subunit 6 [KO:K03037]
100720798  Psmd7; 26S proteasome non-ATPase regulatory subunit 7 [KO:K03038]
100714436  Psmd13; 26S proteasome non-ATPase regulatory subunit 13 [KO:K03039]
101788278  Psmd4; 26S proteasome non-ATPase regulatory subunit 4 [KO:K03029]
100721655  Psmd14; 26S proteasome non-ATPase regulatory subunit 14 [KO:K03030]
100731823  Psmd8; 26S proteasome non-ATPase regulatory subunit 8 [KO:K03031]
100736167  Adrm1; proteasomal ubiquitin receptor ADRM1 isoform X2 [KO:K06691]
100735574  Sem1; 26S proteasome complex subunit SEM1 [KO:K10881]
100716745  Tap1; antigen peptide transporter 1 isoform X1 [KO:K05653] [EC:7.4.2.14]
100717574  Tap2; antigen peptide transporter 2 [KO:K05654] [EC:7.4.2.14]
100735947  Tapbp; tapasin [KO:K08058]
100725599  Pdia3; protein disulfide-isomerase A3 [KO:K08056] [EC:5.3.4.1]
100728485  calreticulin-like [KO:K08057]
100713922  Calr; calreticulin [KO:K08057]
100724396  HLA class I histocompatibility antigen, A-11 alpha chain-like isoform X2 [KO:K06751]
100723126  patr class I histocompatibility antigen, alpha chain E-like isoform X2 [KO:K06751]
100733898  saoe class I histocompatibility antigen, A alpha chain-like [KO:K06751]
100733617  LOW QUALITY PROTEIN: HLA class I histocompatibility antigen, B-18 alpha chain-like [KO:K06751]
100723401  HLA class I histocompatibility antigen, B-46 alpha chain-like isoform X2 [KO:K06751]
100723960  class I histocompatibility antigen, Gogo-OKO alpha chain-like isoform X1 [KO:K06751]
100712777  LOW QUALITY PROTEIN: HLA class I histocompatibility antigen, alpha chain G-like [KO:K06751]
100713317  HLA class I histocompatibility antigen, A-11 alpha chain-like isoform X2 [KO:K06751]
100379556  B2m; beta-2-microglobulin precursor [KO:K08055]
100728254  Snw1; SNW domain-containing protein 1 [KO:K06063]
100724072  Sin3a; paired amphipathic helix protein Sin3a [KO:K11644]
100728529  Hdac1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
100715675  Hdac2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
100720194  Ncor2; nuclear receptor corepressor 2 isoform X1 [KO:K06065]
100727110  Sap30; histone deacetylase complex subunit SAP30 [KO:K19202]
100728721  Sap30l; histone deacetylase complex subunit SAP30L [KO:K19202]
100727165  Cir1; corepressor interacting with RBPJ 1 [KO:K06066]
100716535  Rbpj; recombining binding protein suppressor of hairless isoform X1 [KO:K06053]
100717262  Rbpjl; recombining binding protein suppressor of hairless-like protein [KO:K06053]
100734567  Hes1; transcription factor HES-1 [KO:K06054]
100715029  Fcer2; low affinity immunoglobulin epsilon Fc receptor [KO:K06468]
100735006  Runx3; runt-related transcription factor 3 [KO:K09279]
100724557  Myc; myc proto-oncogene protein isoform X2 [KO:K04377]
100726431  Usp7; ubiquitin carboxyl-terminal hydrolase 7 isoform X1 [KO:K11838] [EC:3.4.19.12]
100724684  Mdm2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
100379269  Tp53; cellular tumor antigen p53 [KO:K04451]
100720449  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
100719739  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
100730773  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
100726538  Ddb2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
100726233  Polk; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
100721722  Traf5; TNF receptor-associated factor 5 isoform X1 [KO:K09849]
100720622  Pik3cd; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100727986  Pik3cb; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
100735084  Pik3ca; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100734206  phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
100730242  Pik3r1; LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649]
100734044  Pik3r2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
100719925  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100714724  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100724315  Akt3; LOW QUALITY PROTEIN: RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
100719582  Map3k14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
100719391  Relb; transcription factor RelB [KO:K09253]
100715820  Nfkb2; LOW QUALITY PROTEIN: nuclear factor NF-kappa-B p100 subunit [KO:K04469]
100732953  Tradd; tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
100734800  Nfkbib; NF-kappa-B inhibitor beta isoform X1 [KO:K02581]
100729666  Nfkbie; NF-kappa-B inhibitor epsilon isoform X1 [KO:K05872]
100733674  Map2k4; dual specificity mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
100731057  Map2k7; dual specificity mitogen-activated protein kinase kinase 7 isoform X2 [KO:K04431] [EC:2.7.12.2]
100722333  Mapk8; mitogen-activated protein kinase 8 isoform X2 [KO:K04440] [EC:2.7.11.24]
100718766  Mapk10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
100714249  Mapk9; mitogen-activated protein kinase 9 isoform X2 [KO:K04440] [EC:2.7.11.24]
100733145  Traf2; TNF receptor-associated factor 2 isoform X2 [KO:K03173] [EC:2.3.2.27]
100727211  Ripk1; receptor-interacting serine/threonine-protein kinase 1 isoform X1 [KO:K02861] [EC:2.7.11.1]
100726100  Map2k3; dual specificity mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
100731419  Map2k6; dual specificity mitogen-activated protein kinase kinase 6 isoform X1 [KO:K04433] [EC:2.7.12.2]
100724974  Mapk11; mitogen-activated protein kinase 11 isoform X1 [KO:K04441] [EC:2.7.11.24]
100723285  Mapk14; mitogen-activated protein kinase 14 isoform X2 [KO:K04441] [EC:2.7.11.24]
100729280  Mapk13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
100728775  Jun; LOW QUALITY PROTEIN: transcription factor AP-1 [KO:K04448]
100727694  Entpd8; ectonucleoside triphosphate diphosphohydrolase 8 isoform X2 [KO:K01510] [EC:3.6.1.5]
100717436  Entpd1; ectonucleoside triphosphate diphosphohydrolase 1 isoform X1 [KO:K01510] [EC:3.6.1.5]
100733912  Entpd3; ectonucleoside triphosphate diphosphohydrolase 3 isoform X1 [KO:K01510] [EC:3.6.1.5]
100728791  Cd40; tumor necrosis factor receptor superfamily member 5 [KO:K03160]
100731707  Cd44; CD44 antigen isoform X1 [KO:K06256]
100713143  Itgal; integrin alpha-L [KO:K05718]
100717967  Icam1; LOW QUALITY PROTEIN: intercellular adhesion molecule 1 [KO:K06490]
100170760  Vim; vimentin [KO:K07606]
100720503  Tnfaip3; tumor necrosis factor alpha-induced protein 3 [KO:K11859] [EC:3.4.19.12]
100713900  Jak3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
100717084  Stat3; signal transducer and activator of transcription 3 isoform X3 [KO:K04692]
100714653  Lyn; tyrosine-protein kinase Lyn isoform X1 [KO:K05854] [EC:2.7.10.2]
100716985  Syk; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
100722637  Nedd4; E3 ubiquitin-protein ligase NEDD4 isoform X1 [KO:K10591] [EC:2.3.2.26]
100727219  Rac1; ras-related C3 botulinum toxin substrate 1 isoform X2 [KO:K04392]
100714123  Btk; tyrosine-protein kinase BTK [KO:K07370] [EC:2.7.10.2]
100712978  Blnk; B-cell linker protein [KO:K07371]
100726796  Plcg2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X2 [KO:K05859] [EC:3.1.4.11]
100720705  Skp2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
100729359  Cdkn1b; cyclin-dependent kinase inhibitor 1B [KO:K06624]
100729808  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
100730596  Ccnd2; G1/S-specific cyclin-D2 [KO:K10151]
100718785  Ccnd3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
100717960  Cdk4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
100732773  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
100716489  Ccna1; cyclin-A1 isoform X1 [KO:K06627]
100716947  Ccna2; cyclin-A2 [KO:K06627]
100734034  Ccne2; G1/S-specific cyclin-E2 [KO:K06626]
100727568  Ccne1; G1/S-specific cyclin-E1 [KO:K06626]
100714324  Cdk2; cyclin-dependent kinase 2 isoform X2 [KO:K02206] [EC:2.7.11.22]
100716297  Rb1; LOW QUALITY PROTEIN: retinoblastoma-associated protein [KO:K06618]
100729531  E2f1; transcription factor E2F1 [KO:K17454]
100714679  E2f2; LOW QUALITY PROTEIN: transcription factor E2F2 [KO:K09389]
100722981  E2f3; transcription factor E2F3 isoform X1 [KO:K06620]
Compound
C00076  Calcium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
PMID:15510157
  Authors
Young LS, Rickinson AB.
  Title
Epstein-Barr virus: 40 years on.
  Journal
Nat Rev Cancer 4:757-68 (2004)
DOI:10.1038/nrc1452
Reference
PMID:21372216
  Authors
Saha A, Robertson ES
  Title
Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
  Journal
Clin Cancer Res 17:3056-63 (2011)
DOI:10.1158/1078-0432.CCR-10-2578
Reference
PMID:21429244
  Authors
Ning S
  Title
Innate immune modulation in EBV infection.
  Journal
Herpesviridae 2:1 (2011)
DOI:10.1186/2042-4280-2-1
Reference
PMID:28408983
  Authors
Stanfield BA, Luftig MA
  Title
Recent advances in understanding Epstein-Barr virus.
  Journal
F1000Res 6:386 (2017)
DOI:10.12688/f1000research.10591.1
Reference
PMID:24586164
  Authors
van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME
  Title
Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
  Journal
PLoS Pathog 10:e1003960 (2014)
DOI:10.1371/journal.ppat.1003960
Reference
PMID:23850008
  Authors
Rajsbaum R, Garcia-Sastre A
  Title
Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.
  Journal
Trends Microbiol 21:421-9 (2013)
DOI:10.1016/j.tim.2013.06.006
Reference
PMID:25704559
  Authors
Hoffmann HH, Schneider WM, Rice CM
  Title
Interferons and viruses: an evolutionary arms race of molecular interactions.
  Journal
Trends Immunol 36:124-38 (2015)
DOI:10.1016/j.it.2015.01.004
Reference
PMID:22110506
  Authors
Spender LC, Inman GJ
  Title
Inhibition of germinal centre apoptotic programmes by epstein-barr virus.
  Journal
Adv Hematol 2011:829525 (2011)
DOI:10.1155/2011/829525
Reference
PMID:23303627
  Authors
Fu Q, He C, Mao ZR
  Title
Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
  Journal
J Zhejiang Univ Sci B 14:8-24 (2013)
DOI:10.1631/jzus.B1200189
Reference
PMID:29116588
  Authors
Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q
  Title
The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.
  Journal
Virol Sin 32:357-368 (2017)
DOI:10.1007/s12250-017-4081-9
Reference
PMID:23435233
  Authors
Melchjorsen J
  Title
Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.
  Journal
Viruses 5:470-527 (2013)
DOI:10.3390/v5020470
Reference
PMID:19498380
  Authors
Hansen TH, Bouvier M
  Title
MHC class I antigen presentation: learning from viral evasion strategies.
  Journal
Nat Rev Immunol 9:503-13 (2009)
DOI:10.1038/nri2575
Reference
PMID:18977445
  Authors
Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ
  Title
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
  Journal
Semin Cancer Biol 18:397-408 (2008)
DOI:10.1016/j.semcancer.2008.10.008
Reference
PMID:21146386
  Authors
Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ
  Title
Viral evasion of T cell immunity: ancient mechanisms offering new applications.
  Journal
Curr Opin Immunol 23:96-103 (2011)
DOI:10.1016/j.coi.2010.11.005
Reference
PMID:27886133
  Authors
Ghosh Roy S, Robertson ES, Saha A
  Title
Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.
  Journal
Biomolecules 6:E46 (2016)
DOI:10.3390/biom6040046
Reference
PMID:22249143
  Authors
Dawson CW, Port RJ, Young LS
  Title
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
  Journal
Semin Cancer Biol 22:144-53 (2012)
DOI:10.1016/j.semcancer.2012.01.004
Reference
PMID:25613730
  Authors
Cai Q, Chen K, Young KH
  Title
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
  Journal
Exp Mol Med 47:e133 (2015)
DOI:10.1038/emm.2014.105
Reference
PMID:17601372
  Authors
Zheng H, Li LL, Hu DS, Deng XY, Cao Y
  Title
Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
  Journal
Cell Mol Immunol 4:185-96 (2007)
Reference
PMID:23793113
  Authors
Ersing I, Bernhardt K, Gewurz BE
  Title
NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.
  Journal
Viruses 5:1587-606 (2013)
DOI:10.3390/v5061587
Reference
PMID:28835489
  Authors
Wang LW, Jiang S, Gewurz BE
  Title
Epstein-Barr Virus LMP1-Mediated Oncogenicity.
  Journal
J Virol 91:e01718-16 (2017)
DOI:10.1128/JVI.01718-16
Reference
PMID:12740915
  Authors
Mori N, Morishita M, Tsukazaki T, Yamamoto N
  Title
Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
  Journal
Int J Cancer 105:661-8 (2003)
DOI:10.1002/ijc.11146
Reference
PMID:25873381
  Authors
Edwards RH, Marquitz AR, Raab-Traub N
  Title
Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
  Journal
MBio 6:e00441-15 (2015)
DOI:10.1128/mBio.00441-15
Reference
PMID:11905817
  Authors
Thorley-Lawson DA
  Title
Epstein-Barr virus: exploiting the immune system.
  Journal
Nat Rev Immunol 1:75-82 (2001)
DOI:10.1038/35095584
Reference
PMID:11669605
  Authors
Eliopoulos AG, Young LS
  Title
LMP1 structure and signal transduction.
  Journal
Semin Cancer Biol 11:435-44 (2001)
DOI:10.1006/scbi.2001.0410
Reference
PMID:14506283
  Authors
Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L
  Title
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
  Journal
J Biol Chem 278:47753-61 (2003)
DOI:10.1074/jbc.M307200200
Reference
PMID:25403939
  Authors
Kang H, Kiess A, Chung CH
  Title
Emerging biomarkers in head and neck cancer in the era of genomics.
  Journal
Nat Rev Clin Oncol 12:11-26 (2015)
DOI:10.1038/nrclinonc.2014.192
Reference
PMID:29932446
  Authors
Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM
  Title
Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.
  Journal
Cancers (Basel) 10:E213 (2018)
DOI:10.3390/cancers10070213
Reference
PMID:19649319
  Authors
Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T
  Title
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
  Journal
PLoS Pathog 5:e1000530 (2009)
DOI:10.1371/journal.ppat.1000530
Reference
PMID:19244339
  Authors
Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
  Journal
J Virol 83:4652-69 (2009)
DOI:10.1128/JVI.02408-08
Reference
PMID:19394062
  Authors
Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
  Journal
Virology 388:236-47 (2009)
DOI:10.1016/j.virol.2009.03.027
Reference
PMID:25635182
  Authors
Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES
  Title
Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
  Journal
Future Virol 4:79-91 (2009)
DOI:10.2217/17460794.4.1.79
Reference
PMID:10818681
  Authors
Longnecker R
  Title
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
  Journal
Adv Cancer Res 79:175-200 (2000)
DOI:10.1016/s0065-230x(00)79006-3
Reference
PMID:30116721
  Authors
El-Sharkawy A, Al Zaidan L, Malki A
  Title
Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.
  Journal
Front Oncol 8:265 (2018)
DOI:10.3389/fonc.2018.00265
Reference
PMID:12811813
  Authors
Dolcetti R, Masucci MG
  Title
Epstein-Barr virus: induction and control of cell transformation.
  Journal
J Cell Physiol 196:207-18 (2003)
DOI:10.1002/jcp.10263
Reference
PMID:21347341
  Authors
Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES
  Title
Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
  Journal
PLoS Pathog 7:e1001275 (2011)
DOI:10.1371/journal.ppat.1001275
Related
pathway
cpoc03050  Proteasome
cpoc04010  MAPK signaling pathway
cpoc04020  Calcium signaling pathway
cpoc04064  NF-kappa B signaling pathway
cpoc04110  Cell cycle
cpoc04115  p53 signaling pathway
cpoc04210  Apoptosis
cpoc04612  Antigen processing and presentation
cpoc04620  Toll-like receptor signaling pathway
cpoc04622  RIG-I-like receptor signaling pathway
cpoc04630  JAK-STAT signaling pathway
cpoc04662  B cell receptor signaling pathway
KO pathway
ko05169   
LinkDB

DBGET integrated database retrieval system